{
  "nctId": "NCT04473326",
  "briefTitle": "Reinforcement Learning in Diabetes Mellitus Trial",
  "officialTitle": "Optimizing Message Framing for Healthy Habits for Patients With Type 2 Diabetes - Phase II (Pragmatic Trial)",
  "protocolDocument": {
    "nctId": "NCT04473326",
    "filename": "Prot_SAP_001.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-04-01",
    "uploadDate": "2023-01-11T22:25",
    "size": 426379,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04473326/document/Prot_SAP_001.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 60,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2021-02-04",
    "completionDate": "2022-01-28",
    "primaryCompletionDate": "2022-01-04",
    "firstSubmitDate": "2020-07-13",
    "firstPostDate": "2020-07-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion criteria:\n\n* Age between 18-84 years\n* Diagnosed with type 2 diabetes mellitus (T2DM) and are prescribed between 1-3 daily oral medications for this disease\n* Currently have a smartphone with a data plan or WiFi at home\n* HbA1c level â‰¥7.5%\n* Basic working knowledge of English\n* Willing and able to set up the platform and adhere to study procedures\n* Either not currently using a pillbox or willing to use electronic pill bottles (EDMs) for diabetes medications for the duration of the study\n\nExclusion criteria:\n\n* Patients with active enrollment in another diabetes trial within Mass General Brigham\n* Patients who receive daily assistance with taking their medications at home\n* Patients who are unable to receive text messages for more than 3 days in a row during the study period",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "84 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Medication Adherence",
        "description": "Medication adherence to type 2 diabetes oral medications (averaged) as measured by the number of dates and times of pillbottle openings in the electronic pill bottles",
        "timeFrame": "6 months"
      }
    ],
    "secondary": [
      {
        "measure": "Glycemic Control",
        "description": "Change in glycated hemoglobin A1c from baseline to end of the 6-month follow-up",
        "timeFrame": "6 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 44,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:09.368Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}